Enterprise Value
3.464B
Cash
453.5M
Avg Qtr Burn
-54.95M
Short % of Float
12.63%
Insider Ownership
0.40%
Institutional Own.
98.82%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DYNE-251 Details Duchenne muscular dystrophy | Phase 1/2 Update | |
DYNE-101 Details Myotonic Dystrophy Type 1 | Phase 1/2 Update |